(Q52096910)

22 April 2018

title

Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees (English)

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

19 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

19 November 2022

2

M. L. Joffret

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

author name string

P. Perrin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

C. Zanetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

H. Bourhy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

C. Gontier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

C. Fritzell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

C. Leclerc

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

P. Sureau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771968

19 November 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

22 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0264410X9190241W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

https://api.elsevier.com/content/article/PII:0264410X9190241W?httpAccept=text/plain

19 November 2022

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

19 November 2022

1 reference

22 April 2018

volume

9

1 reference

22 April 2018

issue

8

1 reference

22 April 2018

page(s)

549-558

1 reference

22 April 2018

Polyoma transformation of hamster cell clones—an investigation of genetic factors affecting cell competence

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0042-6822(62)90290-8

The vaccination of man and other animals against rabies

1

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Immune Responses of Humans to a Human Diploid Cell Strain of Rabies Virus Vaccine: Lymphocyte Transformation, Production of Virus-Neutralizing Antibody, and Induction of Interferon

19 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Cytotoxicity reactions against target cells infected with rabies virus

19 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients.

19 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein

19 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Cell mediated immune response in human antirabies revaccination

19 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine

19 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts

19 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Interleukin-2 augments natural killer cell activity

19 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Interleukin 2 increases protection against experimental rabies.

19 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations

19 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein

19 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule

19 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21/WI-2 cells formed in soft agar

19 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2

19 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay

19 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Complete cloning and molecular organization of a rabies-related virus, Mokola virus

19 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Protein measurement with the Folin phenol reagent

19 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

A microtest for the quantitation of rabies virus neutralizing antibodies

19 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus

19 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

The so-called interleukin-2 inhibitory activity of human serum is largely cytotoxic to mouse cells

19 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production

19 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.

19 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

An enzyme-immunoassay for human interleukin-2.

19 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

19 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0264-410X(91)90241-W

19 November 2022

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018